Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2018-09-25 Board/Management Inform…
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Change in Company Secretary/Compliance Officer
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding a change in company personnel, specifically the resignation of the Company Secretary & Compliance Officer and the interim appointment of the CFO as Compliance Officer. It references Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including changes in management. The content is a management change announcement rather than a financial report, audit, or other filing type. The document length is short and focused solely on management change. Therefore, the appropriate classification is Board/Management Information (MANG).
2018-09-25 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed disclosure addressed to stock exchanges regarding the voting results of the 33rd Annual General Meeting (AGM) held on September 21, 2018. It includes references to the Companies Act, 2013, SEBI regulations, and details about remote e-voting and physical ballots. The document contains the Scrutinizer's Report, which is a formal report on the voting process and results. The content focuses on the official announcement of voting outcomes rather than the AGM presentation materials or the full annual report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail confirm it is not a brief announcement or a simple notice but a full disclosure of voting results.
2018-09-21 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document contains a table listing items with resolutions required, modes of voting, and results. The items include adoption of annual accounts, appointment and re-appointment of directors, and ratification of remuneration for auditors. The presence of voting results and resolutions passed at a meeting indicates this is an official declaration of voting outcomes from a shareholder meeting, likely an Annual General Meeting (AGM). The document length is short (1025 characters), and it focuses on voting results rather than the full report or presentation materials. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2018-09-21 English
AGM/Book Closure
Regulatory Filings Classification · 100% confidence The document text is extremely short (58 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any detailed information. Given the lack of content, this cannot be classified as a full report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous or insufficient content documents.
2018-08-28 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a notice for the 33rd Annual General Meeting (AGM) of Morepen Laboratories Limited scheduled for September 21, 2018. It includes details about the meeting agenda, such as adoption of audited financial statements, appointment and re-appointment of directors, remuneration approvals, and voting procedures. The document is clearly a notice convening the AGM and providing related information to shareholders. It is not the actual annual report or financial statements, but rather the official meeting notice and related procedural information. Therefore, it fits the category of AGM Information (AGM-R). The document length (15,000 characters) and content confirm it is a detailed AGM notice, not a brief announcement or proxy solicitation. Hence, the classification is AGM-R with high confidence.
2018-08-27 English
Investor Presentation
Regulatory Filings
2018-08-13 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.